GasLog Partners (GLOP) is a limited partnership firm which owns, operates and acquires LNG carriers under long-term charter of five years or more. The company has an initial fleet of three LNG carriers with long-term contracts scheduled to expire in 2018 and 2019.
GasLog (GLOG) is the parent company of GasLog Partners. The company is an owner, operator and manager of LNG carriers and works as a part of LNG logistics chain. In April 2012, the company had a fleet of 10 LNG carriers and since then GasLog has increased its capacity by 111% to 21 fully owned ships.
This article discusses the investment positives for the recently listed GasLog Partners. The investment conclusion is that the company is a strong buy for the long term.
Key Investment Positives:�Modern Fleet with Visible Growth
GasLog Partners��initial fleet consists of three LNG carriers with contract expiry in 2018 and 2019. In addition to this, GasLog Partners has the option to purchase 12 LNG carriers over the next three years.
Top 10 Recreation Companies To Watch In Right Now: Take-Two Interactive Software Inc.(TTWO)
Take-Two Interactive Software, Inc. publishes, develops, and distributes interactive entertainment software, hardware, and accessories worldwide. The company develops and publishes software titles for various gaming and entertainment hardware platforms, including PlayStation3 and PlayStation2 computer entertainment systems, PlayStation Portable system, Xbox 360 video game and entertainment system, and Wii and DS systems, as well as for the personal computer and games for Windows. It offers products through its wholly owned labels Rockstar Games and 2K, which publishes titles under 2K Games, 2K Sports, and 2K Play. The company, through its subsidiary, Jack of All Games, also distributes software, hardware, and accessories in North America. Its proprietary brand franchises include Grand Theft Auto; Sid Meier's Civilization; Max Payne; Midnight Club; Manhunt; Red Dead Revolver; Bully; BioShock; Sid Meier's Railroads!; Sid Meier's Pirates!; Carnival Games; and Top Spin, as wel l as licensed brands comprise the sports games Major League Baseball 2K; NBA 2K; and NHL 2K. The company sells its software titles to retail outlets through direct relationships with large retail customers and third party distributors. Its customers include mass merchandisers, specialty retailers, video stores, electronics stores, toy stores, national and regional drug stores, and supermarket and discount store chains. The company was founded in 1993 and is headquartered in New York, New York.
Advisors' Opinion:- [By Victor Mora]
Take-Two Interactive is a developer and provider of interactive entertainment for the use in gaming systems, personal computer, smartphones, and tablets worldwide. The company is reportedly seeing stronger than expected sales from its latest release, Grand Theft Auto V. The stock has been moving higher in recent quarters and is currently trading slightly below highs for the year. Over the last four quarters, earnings and revenues have been rising, which has kept investors upbeat about the company. Relative to its peers and sector, Take-Two Interactive has been a year-to-date performance leader. Look for Take-Two Interactive to continue to OUTPERFORM.
- [By Christopher Freeburn]
On Tuesday, Rockstar Games, a subsidiary of Take-Two Interactive Software (TTWO), released its much anticipated Grand Theft Auto V. The game allows players to navigate a large city, interacting with various unsavory and often violent criminals as they carry out missions. Players get to take part in car chases, shoot-outs and assorted examples of mayhem. The game’s latest edition remains true to the spirit of gleeful carnage found in its previous iterations, USA TODAY notes.
- [By Rick Aristotle Munarriz]
AFP/Getty Images This should be a great time for GameStop (GME). This month's introduction of Sony's (SNE) PlayStation 4 and Microsoft's (MSFT) Xbox One should ring like dinner bells drawing diehard gamers to GameStop's stores. GameStop has assembled a network of 6,488 small-box locations across 15 different countries to cash in on moments like this. It has hosted midnight release parties for both consoles, and with demand exceeding supply, it's a safe bet that a lot of prospective buyers will be circling around their local GameStop locations as new systems arrive throughout the holiday shopping season. However, this may not be as jolly a holiday season as bulls were expecting this time. Blue Christmas GameStop delivered blowout quarterly results on Thursday morning. Sales and earnings clocked in ahead of expectations, but the stock still opened sharply lower because the chain served up a weak profit outlook for the new quarter. It has been seven and eight years, respectively, since Sony and Microsoft updated their consoles, and because of that, the holiday season is supposed to be huge for GameStop. The retailer is forecasting comparable store sales to grow by as much as 9 percent, and that may seem low since these new platforms aren't cheap. The Xbox One sells for $499. The PS4 fetches $100 less, but that price doesn't include the $60 camera accessory gamers will need to buy to get it up to speed with motion-based operations. However, the real shocker in GameStop's report is that it's only looking for a profit between $1.97 a share and $2.14 a share. Even at the high end, we're looking at earnings that are short of the $2.16 a share it earned a year ago and the $2.15 a share that Wall Street was expecting. The two likely culprits for the soft bottom line are weak software and pre-owned sales. And it remains to be seen if either of those two categories will truly bounce back. Thinking Outside of the Xbox Hardware has always been GameStop's lowest margin
- [By Dan Caplinger]
Next Monday, Take-Two Interactive (NASDAQ: TTWO ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed kneejerk reaction to news that turns out to be exactly the wrong move.
Top 5 Logistics Stocks To Own For 2014: Galectin Therapeutics Inc (GALT)
Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc., incorporated on January 26, 2001, is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be used in the treatment of liver fibrosis and fatty liver disease. These two compounds are produced from different natural starting materials, both possessing the property, which lends itself to binding to and inhibiting galectin proteins. GM-CT-01, the Company's product candidate for cancer therapy, is a linear polysaccharide polymer consisted of mannose and galactose that has a defined chemical structure and is derived from a plant source. GR-MD-02, the Company's product for treatment of liver fibrosis and fatty liver disease with inflammation and fibrosis, is a polysaccharide polymer possessing both linear and globular structures, which also is derived from a plant source.
GM-CT-01 has in development for the therapy of colorectal cancer and is in a Phase I/II clinical trial as a combination therapy with a tumor vaccine in patients with advanced melanoma. Based on the completed Phase I and partially completed Phase II clinical trials, the Company is exploring two additional potential indicia for the use of GM-CT-01 in combination with cancer chemotherapy. There are two additional pathways for the development of GM-CT-01 for use in treatment of cancer. GM-CT-01 was found to be generally safe when studied in a Phase I clinical trial in end-stage cancer patients with multiple tumor types alone and in combination with 5-Fluorouracil (5-FU), which is an Food and Drug Administration (FDA)-approved chemotherapy used for treatment of various types of cancer.
Advisors' Opinion:- [By Roberto Pedone]
Galectin Therapeutics (GALT) offers drug research and development to create new therapies for fibrotic disease and cancer. This stock closed up 9.6% to $12.06 in Monday's trading session.
Monday's Volume: 674,000
Three-Month Average Volume: 222,171
Volume % Change: 149%Shares of GALT jumped higher on Monday after Ascendiant initiated coverage on the stock with a buy recommendation.
From a technical perspective, GALT spiked sharply higher here with strong upside volume. This stock has been uptrending for the last three months, with shares ripping higher from its low of $3.95 to its recent high of $13.21. During that move, shares of GALT have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GALT within range of triggering a near-term breakout trade. That trade will hit if GALT manages to take out Monday's high of $12.44 and then once it clears its 52-week high at $13.21 with high volume.
Traders should now look for long-biased trades in GALT as long as it's trending above some near-term support levels at $11 or at $10 and then once it sustains a move or close above those breakout levels with volume that hits near or above 222,171 shares. If that breakout hits soon, then GALT will set up to enter new 52-week-high territory above $13.21, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.
Top 5 Logistics Stocks To Own For 2014: Caribbean International Holdings Inc (CIHN)
Caribbean International Holdings Inc., formerly Caribbean Casino and Gaming Corporation, incorporated on February 12, 2009, is focused in the gaming and entertainment company. The Company has a gaming casino, located in the city of Sousa, in the Dominican Republic. In April 2012, it acquired exclusive rights to distribute Bionic Products' Energy Drinks throughout the Caribbean, South and Central America.
The Sosua Bay Grand Casino provides the gaming and entertainment experience to the Domincan Republic. It is equipped with a state of the art lighting and sound system.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Caribbean International Holdings (OTCMKTS: CIHN), Blue Water Global Group Inc (OTCBB: BLUU) and Metrospaces Inc (OTCMKTS: MSPC) have been getting some attention lately in various investment newsletters and all three have focused their activities in the Caribbean or South America. However, all three have been the subject of paid promotions which have helped to get them mentions in various investment newsletters. With that in mind, will bets on the Caribbean or South America pay off big for these three small cap stocks and their investors? Here is a quick reality check:
Caribbean International Holdings (OTCMKTS: CIHN) is All About Wings, Mechanical Bulls and Stem CellsFormerly known as Caribbean Casino & Gaming Corp, small cap Caribbean International Holdings operates as a holding company. On Friday, Caribbean International Holdings rose 8.39% to $0.0369 for a market cap of $315,400 plus CIHN is up 985.3% over the past year and up 7,280% over the past five years according to Google Finance.
Top 5 Logistics Stocks To Own For 2014: Theravance Inc.(THRX)
Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines for various therapeutic areas, including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The company?s key development programs with GlaxoSmithKline (GSK) include the RELOVAIR, a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease (COPD) and/or asthma; the LAMA/LABA program, a Phase 3 COPD program; and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program, a Phase 2b program for the treatment of COPD, as well as Peripherally Selective Mu-Opioid Receptor Antagonist (P Advisors' Opinion:
- [By Sean Williams]
What: Shares of Theravance (NASDAQ: THRX ) , a biopharmaceutical company that focuses on central nervous system and respiratory disorders, leapt as much as 19% -- its second double-digit jump this week -- following a positive recommendation from the Food and Drug Administration's panel regarding COPD drug Breo Ellipta.
- [By Sean Williams]
Finally, Theravance (NASDAQ: THRX ) made waves after announcing that it would be splitting its business into two separate components: Royalty Management, which will focus on drugs currently in the pipeline in collaboration with GlaxoSmithKline, and Theravance BioPharma, which will continue its line of small-molecule rare disease research. Clearly, this gives investors more visibility of where revenue and profit are coming from, but I think it gives Glaxo even more reason to gobble up the Royalty Management segment because now it doesn't have to buy the remaining pipeline of rare disease research.
- [By Sean Williams]
Things are about to getting very exciting for existing shareholders of biopharmaceutical company Theravance (NASDAQ: THRX ) , with the company announcing its first-quarter results after the closing bell and setting a record date of May 15 for its split into two separate trading entities.
No comments:
Post a Comment